Li Can, He Wei, Wang Nan, Xi Zhipeng, Deng Rongrong, Liu Xiyu, Kang Ran, Xie Lin, Liu Xin
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, School of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing, China.
Department of Clinical Medical Engineering, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Front Bioeng Biotechnol. 2022 May 12;10:907232. doi: 10.3389/fbioe.2022.907232. eCollection 2022.
Tumor metastasis is one of the main causes of cancer incidence and death worldwide. In the process of tumor metastasis, the isolation and analysis of circulating tumor cells (CTCs) plays a crucial role in the early diagnosis and prognosis of cancer patients. Due to the rarity and inherent heterogeneity of CTCs, there is an urgent need for reliable CTCs separation and detection methods in order to obtain valuable information on tumor metastasis and progression from CTCs. Microfluidic technology is increasingly used in various studies of CTCs separation, identification and characterization because of its unique advantages, such as low cost, simple operation, less reagent consumption, miniaturization of the system, rapid detection and accurate control. This paper reviews the research progress of microfluidic technology in CTCs separation and detection in recent years, as well as the potential clinical application of CTCs, looks forward to the application prospect of microfluidic technology in the treatment of tumor metastasis, and briefly discusses the development prospect of microfluidic biosensor.
肿瘤转移是全球癌症发病和死亡的主要原因之一。在肿瘤转移过程中,循环肿瘤细胞(CTC)的分离与分析对癌症患者的早期诊断和预后起着关键作用。由于CTC的稀有性和内在异质性,迫切需要可靠的CTC分离和检测方法,以便从CTC中获取有关肿瘤转移和进展的有价值信息。微流控技术因其独特优势,如低成本、操作简单、试剂消耗少、系统小型化、检测快速和控制精确等,越来越多地用于CTC分离、鉴定和表征的各种研究中。本文综述了近年来微流控技术在CTC分离和检测方面的研究进展,以及CTC的潜在临床应用,展望了微流控技术在肿瘤转移治疗中的应用前景,并简要讨论了微流控生物传感器的发展前景。